Basic Information
Quine Biologics is an expert in structure-based de novo antibody design therapies that maintain therapeutic efficacy over time. Custom-A.B. design focuses on a platform for protein structure, automating and identifying the selection of antibody CDR sequences and conformations. The technology uses denoising diffusion deep learning models to create 3D structural representations for modeling novel antibody-antigen complexes. This technology creates unparalleled specificity and high affinity for antibody-antigen interactions. The result heralds a new era of tailored therapeutics and diagnostic agents.
Quine Biologics, Inc.
United States of America
unclear
--
--
--

